1 – 10 of 48
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Untangling fracture risk in monoclonal gammopathy of undetermined significance : A population-based cohort study
(
- Contribution to journal › Article
-
Mark
Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma
(
- Contribution to journal › Article
-
Mark
A nationwide study on inpatient opportunistic infections in patients with chronic lymphocytic leukemia in the pre-ibrutinib era
(
- Contribution to journal › Article
-
Mark
Comorbidities in multiple myeloma and implications on survival : A population-based study
(
- Contribution to journal › Article
-
Mark
Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance
(
- Contribution to journal › Article
- 2020
-
Mark
A population-based study on serious inpatient bacterial infections in patients with chronic lymphocytic leukemia and their impact on survival
(
- Contribution to journal › Article
- 2019
-
Mark
Parental longevity and survival among patients with multiple myeloma and monoclonal gammopathy of undetermined significance : a population-based study
(
- Contribution to journal › Article
-
Mark
Association of Immune Marker Changes with Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma
2019) In JAMA Oncology(
- Contribution to journal › Article
- 2018
-
Mark
Rapidly changing myeloma epidemiology in the general population : Increased incidence, older patients, and longer survival
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Incidence of multiple myeloma in Great Britain, Sweden, and Malmö, Sweden: the impact of differences in case ascertainment on observed incidence trends.
(
- Contribution to journal › Article